Sign In
Buy SGRY
$15.40
-0.500 (-3.14%)
At Close: Jul 31, 2026
Is Surgery Partners Inc (SGRY) a Bargain After 3.1% Drop? GF Value Says Undervalued
07:40pm, Friday, 31'st Jul 2026
On July 31, 2026, Surgery Partners Inc (SGRY) shares fell 3.1% to a current price of $15.38. This decline comes amid a 52-week trading range of $11.41 to $24.10
Strength Seen in Surgery Partners (SGRY): Can Its 5.3% Jump Turn into More Strength?
07:11am, Thursday, 30'th Jul 2026
Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price inc
Surgery Partners Monetizes Idaho Assets As It Chases Faster Growth
12:56pm, Friday, 24'th Jul 2026
Surgery Partners, Inc. (NASDAQ:SGRY) stock is trading higher on Friday as the company announced a significant transaction involving the sale of its ownership interests in Idaho Falls facilities to Int
BRENTWOOD, Tenn., July 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today
Fast-paced Momentum Stock Surgery Partners (SGRY) Is Still Trading at a Bargain
09:56am, Wednesday, 08'th Jul 2026
Surgery Partners (SGRY) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stock
Why Fast-paced Mover Surgery Partners (SGRY) Is a Great Choice for Value Investors
09:55am, Monday, 22'nd Jun 2026
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Surgery Partners (SGRY) could be a great choice. It is one of the several stocks tha
Wall Street Analysts See a 26.14% Upside in Surgery Partners (SGRY): Can the Stock Really Move This High?
10:55am, Thursday, 18'th Jun 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 26.1% in Surgery Partners (SGRY). While the effectiveness of this highly sought-after metric is questionable, t
Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?
02:34pm, Wednesday, 10'th Jun 2026
Surgery Partners operates a massive nationwide network of outpatient surgical facilities and hospitals. Viemed Healthcare is a high-growth specialist focusing on home-based respiratory care and diseas
Surgery Partners, Inc. (SGRY) Q1 2026 Earnings Call Transcript
03:41pm, Tuesday, 05'th May 2026
Surgery Partners, Inc. (SGRY) Q1 2026 Earnings Call Transcript
Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates
10:15am, Tuesday, 05'th May 2026
Surgery Partners (SGRY) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to earnings of $0.04 per share a year ago.
Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance
07:30am, Tuesday, 05'th May 2026
BRENTWOOD, Tenn., May 05, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today
AUNA vs. SGRY: Which Hospital Stock Looks More Attractive Now?
09:15am, Wednesday, 22'nd Apr 2026
Auna S.A. gains from Peru growth, stabilizing Mexico and Colombia cash flow focus, while Surgery Partners faces earnings cuts and headwinds.
Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details
03:08pm, Friday, 17'th Apr 2026
BRENTWOOD, Tenn., April 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced th
Reviewing Progyny (NASDAQ:PGNY) & Surgery Partners (NASDAQ:SGRY)
02:18am, Monday, 13'th Apr 2026
Progyny (NASDAQ: PGNY - Get Free Report) and Surgery Partners (NASDAQ: SGRY - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two comp
SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP INVESTIGATES
09:00am, Wednesday, 01'st Apr 2026
Surgery Partners reported AN Adjusted EBITDA decline of 4.2% in Q4 following projections for continued expanding margins -- Levi & Korsinsky, LLP investigates potential securities law violations NEW
